Skip to content
Disclosery

Rosalind Advisors, Inc.

Follow

13F filer, CIK 1622627, TORONTO, Ontario, Canada

Rosalind Advisors, Inc. reported $195,569,194 across 40 holdings for the quarter ended 2024-12-31, in a 13F-HR/A filed 2025-02-14. Its ten largest share positions make up 69.28% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR/A 0001622627-25-000016

Period
2024-12-31
Reported value
$196M
Holdings
40
Top 10 weight
69.28%
New
22
Sold out
15

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CHIMERIX INC COMnew+3,050,000$10.6M
URGNnew+870,000$9.27M
SVRAnew+2,654,944$8.15M
FENCnew+1,259,876$7.96M
HELPnew+810,918$7.15M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CRMDexited-1,475,000-$11.9M
CYBIN INCexited-1,075,105-$9.56M
CELLECTAR BIOSCIENCES INCexited-3,671,550-$7.86M
VERONA PHARMA PLCreduced-125,000-$5.8M
OPTINOSE INCexited-8,287,503-$5.55M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2024

Share positions as resolved from 13F-HR/A 0001622627-25-000016, largest first. % of portfolio is the value over $185,657,489, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
DCTHDELCATH SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,650,389 shares; 2024Q4: 2,650,389 shares 2,650,389$31.9M17.19%02026-10-13, Form 4: converted 3,627 shares on 2026-10-13 Timeline
MYOMYOMO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,021,391 shares; 2024Q4: 2,998,945 shares 2,998,945$19.3M10.4%-22,446Timeline
MDWDMEDIWOUND LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 628,050 shares; 2024Q4: 628,050 shares 628,050$11.2M6.02%0Timeline
CHIMERIX INC COMCHIMERIX INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 3,050,000 shares 3,050,000$10.6M5.72%new
XERSXERIS BIOPHARMA HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,104,995 shares; 2024Q4: 3,104,995 shares 3,104,995$10.5M5.67%0Timeline
ABEOABEONA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,832,000 shares; 2024Q4: 1,805,390 shares 1,805,390$10.1M5.42%-26,610Timeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 885,000 shares; 2024Q4: 1,128,700 shares 1,128,700$9.64M5.19%+243,700Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 870,000 shares 870,000$9.27M4.99%newTimeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 2,654,944 shares 2,654,944$8.15M4.39%newTimeline
FENCFENNEC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,259,876 shares 1,259,876$7.96M4.29%newTimeline
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 810,918 shares 810,918$7.15M3.85%newTimeline
VERONA PHARMA PLCVERONA PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 275,000 shares; 2024Q4: 150,000 shares 150,000$6.97M3.75%-125,000
NSPRINSPIREMD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,514,046 shares; 2024Q4: 2,495,783 shares 2,495,783$6.56M3.54%-18,263Timeline
OPTINOSE INCOPTINOSE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 876,996 shares 876,996$5.86M3.16%new
PROFPROFOUND MED CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 485,973 shares; 2024Q4: 692,185 shares 692,185$5.2M2.8%+206,212Timeline
VSTMVERASTEM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 900,000 shares 900,000$4.65M2.51%newTimeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 750,000 shares; 2024Q4: 1,062,500 shares 1,062,500$4.38M2.36%+312,500Timeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 260,000 shares 260,000$3.15M1.7%newTimeline
PYPDPOLYPID LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 679,168 shares; 2024Q4: 1,018,021 shares 1,018,021$3.09M1.67%+338,853Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 781,423 shares; 2024Q4: 707,625 shares 707,625$2.67M1.44%-73,798Timeline
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 303,864 shares; 2024Q4: 303,864 shares 303,864$2.57M1.39%0Timeline
ACOGALPHA COGNITION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 252,753 shares 252,753$1.49M0.8%newTimeline
FLNAFILANA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 417,400 shares 417,400$985K0.53%newTimeline
BFRIBIOFRONTERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 495,490 shares; 2024Q4: 811,918 shares 811,918$885K0.48%+316,428Timeline
KPRXKIORA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 250,555 shares 250,555$827K0.45%newTimeline
TLPHTALPHERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 758,966 shares; 2024Q4: 613,939 shares 613,939$322K0.17%-145,027Timeline
OWLTOWLET INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 270,000 shares; 2024Q4: 49,441 shares 49,441$220K0.12%-220,559Timeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 100,000 shares 100,000$52K0.03%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
FILANA THERAPEUTICS INCFILANA THERAPEUTICS INC COMput417,400$3.65M+50,000
BIOMEA FUSION INCBIOMEA FUSION INC COMput910,700$2.76Mnew
CORMEDIX INCCORMEDIX INC COMcall183,900$920K-516,100
EDGEWISE THERAPEUTICS INCEDGEWISE THERAPEUTICS INC COMput237,500$808Knew
ISHARES TRISHARES TR PUTput200,000$404Knew
INVESCO QQQ TRINVESCO QQQ TR PUTput100,000$356Knew
SPDR SERIES TRUSTSPDR SERIES TRUST PUTput800,000$311Knew
NEUMORA THERAPEUTICS INC.NEUMORA THERAPEUTICS INC. COMput136,600$300Knew
LEXICON PHARMACEUTICALS INCLEXICON PHARMACEUTICALS INC COM NEWcall1,278,900$282Knew
RELMADA THERAPEUTICS INCRELMADA THERAPEUTICS INC COMput100,000$95Knew
SPDR SERIES TRUSTSPDR SERIES TRUST ST STR SP BIOTcall1,400,000$22Knew
CANDEL THERAPEUTICS INCCANDEL THERAPEUTICS INC COMput262,500$480new

Sold out in Q4 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CRMDCORMEDIX INC1,475,000$11.9Mshares
CYBIN INCCYBIN INC1,075,105$9.56Mshares
CELLECTAR BIOSCIENCES INCCELLECTAR BIOSCIENCES INC3,671,550$7.86Mshares
OPTINOSE INCOPTINOSE INC8,287,503$5.55Mshares
OUTLOOK THERAPEUTICS INCOUTLOOK THERAPEUTICS INC450,000$2.4Mshares
Veru IncVeru Inc2,694,503$2.07Mshares
ABVXABIVAX SA139,983$1.61Mshares
KIORA PHARMACEUTICALS INCKIORA PHARMACEUTICALS INC255,555$935Kshares
FBIOFORTRESS BIOTECH INC502,828$727Kshares
DERMJOURNEY MED CORP105,917$598Kshares
QQQINVESCO QQQ TR150,000$220Kput
NAMSNEWAMSTERDAM PHARMA COMPANY10,123$168Kshares
XBISPDR SERIES TRUST200,000$164Kput
CLEARSIDE BIOMEDICAL INCCLEARSIDE BIOMEDICAL INC127,220$162Kshares
VOR BIOPHARMA INCVOR BIOPHARMA INC76,685$53.7Kshares

How Q4 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001622627-25-000008 superseded2025-02-11acceptance time not in the bulk data set
13F-HR/A 0001622627-25-000016 baserestatement2025-02-14acceptance time not in the bulk data set